Drug intelligence / Profile preview

Ferrocebrina

Development stage: Unknown
Modality: Small Molecules
Administration: Oral

Overview

**Ferrocebrina** is a pharmaceutical preparation used as an iron supplement, primarily indicated for the treatment and prevention of iron deficiency anemia. Its mechanism of action is based on providing elemental iron, which is incorporated into hemoglobin and myoglobin. These proteins are responsible for oxygen transport and storage in the body, supporting the production of healthy red blood cells. Typically, these iron supplements can be provided as ferrous salts such as ferrous fumarate or ferrous sulfate.

Brand names: Ferrocebrina

Beyond the preview

Go deeper on Ferrocebrina.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferrocebrina.

Explore the full profile